Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
PaperCitations, authors & open-access status
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 392 citations, 2023 year and closed oa status.
392
Citations
2023
Year
closed
OA Status